Post by MicroPort

79,945 followers

What are the key findings from the TARGET-FIRST study? Prof. Guillaume CAYLA explains the study design and discusses how a 1-month DAPT strategy may reduce bleeding while maintaining ischemic protection in carefully selected AMI patients after PCI. The TARGET-FIRST trial, recently recognized as a landmark study by the European Heart Journal, continues to shape discussions on the future of personalized antiplatelet therapy. šŸŽ„ Watch the full interview : https://lnkd.in/eDSuPhi4 Follow #TARGETFIRSTPerspectives for expert voices from Europe, Asia, and the Americas on what TARGET-FIRST means for everyday clinical practice. #ShortDAPT #TargetFirst #PCI #InterventionalCardiology

Post content

Video Content